Sunday, November 22, 2026
HomeHealth InsurancePractical Strategies to Fix the No Surprises Act and Curb Costs: Themes...

Practical Strategies to Fix the No Surprises Act and Curb Costs: Themes from a CHIR Briefing


By Shiva Ranganathan

On November 12, CHIR hosted a briefing on the cost of the No Surprises Act (NSA) independent dispute resolution (IDR) process. The NSA was designed to protect patients from surprise medical bills while containing costs through IDR. Prior to the NSA, patients who were treated by doctors whom they didn’t choose and whom they didn’t choose and who were out-of-network (i.e. because of a medical emergency or while they were in an in-network facility), could face exorbitant balance bills. The NSA prohibited those bills, held patients harmless, and established the IDR process to resolve payment disputes between the out-of-network clinicians and payers. 

The CHIR briefing featured remarks from Senate HELP Committee staffer Romney Gripado, an analysis of federal IDR data from CHIR researcher Kennah Watts, and a panel that included Melissa Bartlett from the ERISA Industry Committee (ERIC), Sophia Tripoli from Families USA, Jackson Hammond from the Paragon Institute, and CHIR’s own Jack Hoadley. As described in more detail below, four main themes arose from the discussion: IDR volume and spending have far exceeded expectations, misaligned incentives may be driving outcomes, employers and workers are absorbing the costs, and panelists agree reform is a priority but differ on how it should look.

IDR Volume Has Far Exceeded Expectations

Speakers agreed that the NSA has succeeded in protecting consumers by preventing millions of surprise bills, but the law’s cost containment priority has been undermined by the arbitration process. CHIR estimates that the IDR system generated more than $22 billion in costs between 2022 and 2025. Kennah Watts reported that costs reached more than $16 billion in 2025 alone, nearly 3.5 times the previous year. These totals reflect awards that exceed the qualifying payment amount (QPA), as well as fees and administrative costs.

Volume plays a central role in costs. Federal agencies expected about 17,000 emergency and non-emergency disputes per year, but providers filed more than 2.6 million in 2025 alone, which is over 7,000 disputes each day. Jack Hoadley noted that early data suggest 2026 is on track to exceed 4 million disputes, so costs will likely continue to ascend. Although only about 6% of NSA-covered claims enter IDR, this small share of claims is generating substantial costs.

Misaligned Incentives May Be Driving Outcomes

Panelists described the IDR system as incentivizing higher volume and awards for certain provider groups. As Watts mentioned in her presentation, five provider groups account for roughly three-quarters of all disputes. Four are private equity-backed physician organizations, and the fifth is an intermediary company that handles disputes and represents providers. Harvard researchers estimate that up to $1.4 billion in provider awards went to representative middlemen. The four staffing organizations have extremely high dispute win rates of 90-96%, compared with 85% for all providers, including unrepresented ones, and some receive awards 6-10 times the median in-network rates. Median awards for neurology and plastic surgery more than doubled between 2023 and 2025, and now range from 24-30 times median in-network rates.

Jackson Hammond added that the IDR entities are paid for each dispute, and more than 99% of disputes are filed by providers, which makes providers their primary “customers.” Dispute resolution entities with higher provider win rates attract more cases, with roughly three-quarters of disputes going to entities with provider win rates of 88% or higher. Because of this, IDR entities are incentivized to reward providers, and insurers tend to lose no matter how they change their behavior. Hammond pointed to Cigna, which raised its offers to about 3.5 times the QPA, yet it still lost roughly three-quarters of disputes. Hoadley and Hammond noted that most plan offers are at or above the QPA, so outlier low-ball offers do not explain provider win rates.

Employers and Workers Absorb the Costs

Melissa Bartlett emphasized that someone–mainly the employer health plan–has to pay these awards. Two-thirds of workers with employer-sponsored insurance are in self-funded plans, where no insurer absorbs the cost. Payments come from employers’ funds and workers’ wages, but employers are often unaware of how claims are handled because they outsource claims management to third-party administrators (TPAs). In interviews with large self-funded employers, ERIC found that IDR awards add between 1-6% to employers’ total health spending. One employer paid $3.5 million in IDR awards in 2025 and was on pace for about $12 million in 2026, mostly tied to a single ER operator. Another attributed 1-3% of annual cost growth to IDR, comparable to its GLP-1 spending.

Sophia Tripoli said these costs are reaching consumers through higher premiums, higher out-of-pocket costs, and lower wages, and she tied the issue to voters’ concerns about affordability and health care costs. Hammond expected the short-term premium increase to be relatively small, but warned of long-term risk if more providers decide to rely on IDR, rather than negotiate in-network rates.

How Should Reform Look?

Romney Gripado of the Senate HELP Committee said that Chairman Bill Cassidy’s office will soon release legislation focused on IDR oversight, transparency, timely payment to providers, and realignment of arbitration incentives. She also credited the administration for some recently adopted regulations and for denying the recertification of two IDR entities.

Panelists broadly agreed that a legislative fix is needed, but differed on what that fix should look like. Bartlett and Tripoli argued for a payment standard tied to a fair market rate. Tripoli pointed to California and Ohio as examples, where state payment standards have led to fewer disputes and awards closer to in-network rates. Hammond argued for a payment cap based on in-network rates for emergency services, but suggested eliminating balance billing protections for services consumers schedule in advance. Tripoli responded that reversing the NSA’s patient protections would frustrate many consumers. For Hoadley, the central question policymakers face is whether to revise arbitration or eliminate it. Hoadley added that Congressional Budget Office estimates of savings from any fix will influence how quickly the policy advances.

Takeaways

The NSA has protected patients from surprise billing, but the IDR process is generating costs that it was meant to contain, which are cascading down to employers and consumers. Panelists agreed that reform is needed, but vary in their recommendations for reform. Watch the recorded briefing at this link.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments